Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Atlanticus Holdings Corporation announced record second quarter 2026 financial results with net income attributable to common shareholders rising 67.2% to $47.4 million, driven by a 89.0% increase in total operating revenue to $744.3 million. Managed receivables surged 126.2% to $6.9 billion mainly due to the Mercury acquisition and organic growth …
HP Inc. announced that it will report its third quarter fiscal 2026 earnings on August 26, 2026, with a live webcast of a conference call reviewing the financial results. The company also confirmed its participation in key investor conferences including Goldman Sachs Communacopia + Technology Conference, Citi's Global TMT Conference, and J.P. Morga…
DoubleVerify reported a 3% revenue increase in Q2 2026 compared to Q2 2025, with total revenue reaching $193.8 million and a healthy adjusted EBITDA margin of 34%. The company entered into a merger agreement to be acquired by Nielsen Holdings, leading to the suspension of earnings calls and guidance updates during the transaction period.
Power Solutions International announced second quarter 2026 financial results with net sales of $152.5 million, down 21% from the prior year, and net income of $16.9 million, a 67% decline. The company improved gross margin sequentially by 420 basis points due to operational improvements, despite unfavorable product mix and ongoing ramp-up costs. T…
Flyte, operating under Catheter Precision, Inc. (NYSE American: VTAK), achieved record revenues in July 2026, increasing by 102% over June to approximately $640,000. Growth was driven by its enhanced direct-to-consumer private aviation platform, strategic partnerships across various industries, and influencer marketing efforts, which contributed to…
ESCO Technologies Inc. announced a strong third quarter fiscal 2026 performance, highlighting a 14% increase in sales to $339 million, a 38% increase in adjusted EPS to $2.20, and record backlog of $1.54 billion. The company raised its full-year sales guidance to $1.30-$1.33 billion and adjusted EPS guidance to $8.30-$8.40, signaling robust growth …
Valhi, Inc. reported net income of $22.3 million ($0.78 per share) in Q2 2026, a significant increase from $0.9 million ($0.03 per share) in Q2 2025. The company's Chemicals segment showed strong sales and operating income growth due to market share gains, cost reductions, and strategic price increases. The Component Products segment also experienc…
CytomX Therapeutics announced its Q2 2026 financial results and provided updates on its clinical pipeline, focusing on Varsetatug masetecan (Varseta-M) for colorectal cancer with Phase 1 data expected by the end of 2026 and planned registrational studies in 2027. Expansion into other GI cancers and combination studies are underway. The company also…
KULR Technology Group, a NYSE American-listed company specializing in high-power energy systems for AI and mission-critical applications, announced its Q2 2026 earnings call on August 13, 2026. The company will release its financial results prior to the call and provide details for investors to participate.
Super League, a Nasdaq-listed company specializing in audience intelligence and media activation for the global gaming population, will release its Q2 2026 financial results on August 14, 2026, accompanied by a live webinar to discuss the results.
LiqTech International, a clean technology firm specializing in advanced filtration systems, will release its second quarter 2026 financial results on August 12, 2026, before market open. A conference call and webcast will follow to discuss the results.
The E.W. Scripps Company reported Q2 2026 revenue of $490 million, a 9.2% decline year-over-year. The company recorded a substantial non-cash goodwill and intangible asset impairment charge of $1.1 billion attributed to challenges in its national advertising market and shifting audience measurement dynamics, resulting in a net loss of $1.2 billion …
Clarus Corporation, a leader in outdoor equipment, reported its second quarter 2026 financial results showing a 1.6% increase in sales to $56.2 million and a return to net income of $4.7 million compared to a net loss in the prior year. The Outdoor segment grew by 8.5%, driven by better inventory focus and product mix, while the Adventure segment d…
Microchip Technology Incorporated announced fiscal Q1 2027 results with net sales of $1.485 billion, a 38% increase year-over-year and above guidance. Both GAAP and non-GAAP profits saw significant improvements, with GAAP EPS of $0.37 and non-GAAP EPS of $0.76 per diluted share. The company strengthened operational metrics including reduced invento…
X4 Pharmaceuticals reported Q2 2026 financial results highlighting operational improvements in their Phase 3 4WARD trial for chronic neutropenia, with enrollment underway across 110+ global sites. The company secured European Commission marketing authorization for XOLREMDI® (mavorixafor), the first treatment for WHIM syndrome in the EU, partnering …
Ryman Hospitality Properties, Inc. (NYSE: RHP) reported its financial results for Q2 2026, delivering all-time quarterly record consolidated revenue of $749 million and adjusted EBITDAre of $258.3 million. The Hospitality segment saw record same-store revenue driven by a premium group customer strategy and increased average daily rates, while the E…
HCI Group, Inc. reported a robust second quarter 2026 with pre-tax income rising to $111 million from $94 million a year earlier and diluted EPS increasing to $5.60 from $5.18. The company grew gross premiums earned by 6% driven by higher policy volume, improved net investment income, and higher other revenues through their Exzeo insurance technolo…
Vaalco Energy, Inc. announced a quarterly cash dividend of $0.0625 per share for Q3 2026, payable on September 22, 2026. This marks the company's 19th consecutive quarterly dividend, reflecting strong cash generation and a commitment to shareholder returns alongside ongoing capital investments in its diversified energy asset portfolio across Africa…
Kingstone Companies, Inc., a regional property and casualty insurance holding company, reported its best quarter ever for Q2 2026, with diluted EPS increasing 35% year-over-year to $1.05. Net premiums earned rose by 31%, driven by strong growth in direct premiums written and robust New York personal lines results. The company improved its GAAP net …
Globus Medical reported second quarter 2026 financial results with worldwide net sales increasing 5.9% to $789.6 million, driven by strong US and international spine segment growth. Non-GAAP diluted EPS surged 55.8% to $1.34, excluding prior year acquisition gains. The company reaffirmed full-year 2026 revenue guidance of $3.18-3.22 billion and rai…
Seneca Foods Corporation announced a significant year-over-year increase in net sales for Q1 fiscal 2027 driven by volume growth, higher selling prices, and product mix benefits, notably from its Green Giant Frozen acquisition. Despite a decrease in gross margin percentage, adjusted net earnings and EBITDA improved substantially. The company highli…
Rank One Computing Corporation (ROC), a U.S. leader in Vision AI technology, announced it will release its financial results for the second quarter of 2026 after market close on August 13, 2026, followed by a management conference call to discuss the results.
Valhi, Inc., operating in chemicals, component products, and real estate management, declared a regular quarterly dividend of $0.08 per share payable on September 24, 2026.
Alta Equipment Group Inc. reported its second quarter 2026 financial results, showing sequential revenue growth across all segments despite a slight year-over-year revenue decline. The company improved new and used equipment sales gross margins, service gross profit percentages, and reduced interest expenses. Adjusted EBITDA remained stable year-ov…
Cognition Therapeutics reported Q2 2026 financial results highlighting progress in their Phase 3 clinical trial planning for zervimesine (CT1812), a treatment for dementia with Lewy bodies (DLB) psychosis. They received FDA feedback clarifying trial design, secured a patent allowance extending intellectual property protection through 2045, and exte…
